Sarbecovirus ORF6 proteins antagonize interferon signaling
Topics in Antiviral Medicine
; 29(1):29, 2021.
Article
in English
| EMBASE | ID: covidwho-1250364
ABSTRACT
Background:
SARS-CoV and SARS-CoV-2 are closely related, both belong to the genus Betacoronavirus, subgenus Sarbecovirus. The ORF6 gene is commonly encoded in all Sarbecoviruses, including SARS-CoV and SARS-CoV-2, while no orthologs are found in the other Betacoronaviruses. A comprehensive proteome analysis by Gordon et al. has recently suggested that SARS-CoV-2 ORF6 interacts with two cellular proteins, RAE1 and NUP98, via its C-terminal region, but the biological function of ORF6 remains unknown.Methods:
For the cell culture experiments, we generated a series of Sarbecovirus ORF6 expression plasmids. We monitored human IFNB1 promoter activity in the presence of ORF6 by a luciferase reporter assay. To determine the residue(s) that are responsible for the anti-interferon (IFN) activity of ORF6, we aligned and compared the ORF6 amino acid sequences and prepared a series of ORF6 mutants. To verify whether ORF6 interacts with RAE1 and NUP98 proteins, we performed co-immunoprecipitation assay.Results:
The cell culture experiments showed that ORF6 inhibits the induction of type I IFN upon viral infection. Intriguingly, the anti-IFN activity of ORF6 proteins of SARS-CoV-2 lineages was more potent than that of SARS-CoV lineages. Mutational analyses identified the two residues in the C-terminal region of ORF6 that determines the difference on the anti-IFN activity between SARS-CoV-2 ORF6 and SARS-CoV ORF6. Moreover, the co-immunoprecipitation assay revealed that ORF6 binds to RAE1 and NUP98 via its C-terminus, thereby inhibiting the expression of IFNB1 mRNA. Finally, in approximately 0.2% of the SARS-CoV-2 isolates during current pandemic, we identified naturally occurring variants that encode the truncated ORF6 gene by frameshift mutation and potentially result in the incompetence of exhibiting anti-IFN effect.Conclusion:
Our findings suggest that the poor IFN activation observed in COVID-19 patients can at least in part be ascribed to ORF6. Furthermore, we provide evidence suggesting that the emergence of the SARS-CoV-2 variants that lost a functional ORF6 gene may contribute to the attenuation of viral pathogenicity.
Search on Google
Collection:
Databases of international organizations
Database:
EMBASE
Language:
English
Journal:
Topics in Antiviral Medicine
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS